MILLENNIUM MANAGEMENT LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in CADL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,194,421

+$4,497,404 QoQ

Shares Held

1,060,086

+675.7% QoQ

Ownership

1.45%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. CADL ranks #169 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	1,262,511	$238,677,704
2	INSM	INSMED Inc	1,157,786	$189,321,166
3	BMRN	Biomarin Pharmaceutical Inc	3,010,308	$170,052,298
4	TERN	Terns Pharmaceuticals, Inc.	3,011,558	$158,769,337
5	ALNY	Alnylam Pharmaceuticals, Inc.	447,887	$148,192,371
6	FOLD	AMICUS THERAPEUTICS, INC.	7,908,459	$114,356,317
7	ARDX	Ardelyx, Inc.	17,842,370	$106,875,796
8	BLTE	Belite Bio, Inc	570,088	$90,894,830

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,194,421	1,060,086	+675.7%	Shares	Sole	2026-05-15
2025-09-30	$697,017	136,670	-34.5%	Shares	Sole	2025-11-14
2025-03-31	$1,178,640	208,609	+559.6%	Shares	Sole	2025-05-15
2024-12-31	$274,513	31,626	+130.6%	Shares	Sole	2025-02-14
2024-09-30	$95,024	13,712	-20.9%	Shares	Sole	2024-11-14
2024-06-30	$107,532	17,344	+16.8%	Shares	Sole	2024-08-14
2022-09-30	$46,610	14,844	+13.3%	Shares	Sole	2022-11-14
2021-12-31	$102,488	13,106	+23.1%	Shares	Sole	2022-02-14
2021-09-30	$115,402	10,646	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.